Bpc 157 bone healing: 2025's Crucial Warning. In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Covering Every FDA Oncology Approval From October 2025 CURE FDA to weigh easing limits on unproven peptides promoted by RFK Jr. FDA Moves to Reevaluate Several Peptides American Med Spa Association